Merit Medical Systems Stock News

Stents Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while launching

Vascular Snare Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while

Y Intercept Hong Kong Ltd purchased a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 3,130 shares of the medical instruments suppliers stock, valued at approximately $202,000. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in []

Bank of America Corp DE cut its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 1.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 358,213 shares of the medical instruments suppliers stock after selling 3,944 shares during the period. Bank of America Corp DEs holdings []

Canada Varicose Vein Treatment Devices Market: Overview As per the study published in NCBI or National Centre for Biotechnology Information, over 3.7 million people in Canada are living with varicose veins. This has considerably heightened the need for effective and enhanced

Market Intelligence Data has released a new report on the global “Metal Partially Covered Biliary Stent market”. The document gives a complete evaluation of the market. It understands market development through in-depth insights, tracking historical results and analysing current scenarios

Credit Suisse AG boosted its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 9.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 48,561 shares of the medical instruments suppliers stock after buying an additional 4,199 shares during the period. Credit Suisse AGs holdings in Merit Medical Systems were worth $3,140,000 at the []

Millennium Management LLC acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 204,597 shares of the medical instruments suppliers stock, valued at approximately $13,229,000. Millennium Management LLC owned about 0.36% of Merit Medical Systems at []

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Merit Medical (MMSI), in the third quarter, benefits from revenue growth in its Cardiovascular segment, and from the majority of the product categories within its Cardiovascular unit.

Merit Medical Systems, Inc (MMSI) CEO Fred Lampropoulos on Q3 2021 Results - Earnings Call Transcript

Merit Medical (MMSI) delivered earnings and revenue surprises of 18.18% and 2.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.

SOUTH JORDAN, Utah, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnost

Backed by robust long-term prospects, investors can add three lucrative MedTech stocks, MMSI, ITGR and OFIX, to their watchlist.